XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue under collaboration agreements $ 10 $ 464 $ 30 $ 1,127
Operating expenses:        
Research and development (including related party amounts of $484, $572, $1,075 and $1,112, respectively) 7,308 4,350 13,860 9,773
General and administrative (including related party amounts of $181, $106, $518 and $271, respectively) 13,305 2,458 25,486 4,797
Total operating expenses 20,613 6,808 39,346 14,570
Loss from operations (20,603) (6,344) (39,316) (13,443)
Other income (expense), net 3,233 (76) 6,985 (227)
Net loss (17,370) (6,420) (32,331) (13,670)
Change in unrealized gains and losses on available-for-sale securities (248) 0 (587) 0
Comprehensive loss $ (17,618) $ (6,420) $ (32,918) $ (13,670)
Earnings Per Share, Basic $ (0.18) $ (0.21) $ (0.34) $ (0.45)
Earnings Per Share, Diluted $ (0.18) $ (0.21) $ (0.34) $ (0.45)
Weighted Average Number of Shares Outstanding, Basic 94,911,268 30,606,773 94,571,180 30,488,749
Weighted Average Number of Shares Outstanding, Diluted 94,911,268 30,606,773 94,571,180 30,488,749